findinEsegui ricerca
Image

hMPV

When a virus creates jobsWhen a virus creates jobs

In 2001 virologists in Rotterdam, The Netherlands discovered a new virus that causes serious respiratory illnesses mainly in young children. The discovery was the beginning of a successful company that enabled the development and production of a range of diagnostic products. This led to substantial job creation and made a positive contribution to public health.

May 2013

Tenofovir

Controlling HIV with a trojan horseControlling HIV with a trojan horse

Being an HIV-infected person in the 1980s meant having a mostly lethal condition and taking up to twenty pills a day to postpone the inevitable death sentence. Thanks to research done in a collaboration between Belgian, Czech and United States researchers, an HIV infection is now rather a chronic disease for which only one pill a day is sufficient to lead a virtually normal life.

May 2013

Ovizio

Expanding views with 3D microscopesExpanding views with 3D microscopes

When scientists from the Belgian Université Libre de Bruxelles (ULB) met technology transfer professionals, they could not foresee how only a couple of years later they would be heading a firm developing and selling a full range of microscopes based on digital holography. The basic technology was developed at the university, the applications by the spin-off company Ovizio.

May 2013

Cochlear implants

Better speech recognition with cochlear implantsBetter speech recognition with cochlear implants

Cochlear implants greatly improve the quality of life for severely hearing-impaired people. However, understanding speech in noisy conditions remains a challenge. Scientists from the University of Leuven in Belgium and market leader Cochlear are developing software that improves signal processing in cochlear implants, enabling better speech recognition.

January 2013
You have selected
Knowledge Transfer Activity
Research collaboration
This project has received funding from the European Union’s Seventh Programme for 
research, technological development and demonstration under grant agreement No 305128
 
  ENTENTE is supported by the European Commission and coordinated by Inserm-Transfert SA